{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:43:47Z","timestamp":1773168227701,"version":"3.50.1"},"reference-count":106,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1097\/crd.0b013e31824c866e","type":"journal-article","created":{"date-parts":[[2012,2,4]],"date-time":"2012-02-04T11:09:59Z","timestamp":1328353799000},"page":"167-176","source":"Crossref","is-referenced-by-count":51,"title":["Carcinoid Heart Disease"],"prefix":"10.1097","volume":"20","author":[{"given":"Chandrasekar","family":"Palaniswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Frishman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert S.","family":"Aronow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2","article-title":"An analysis of 8305 cases of carcinoid tumors.","volume":"79","author":"Modlin","year":"1997","journal-title":"Cancer"},{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJM199903183401107","article-title":"Carcinoid tumors.","volume":"340","author":"Kulke","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-2-20210203","first-page":"4","article-title":"Metastatic carcinoid of the small intestine with severe valvular defects especially in the right part of the heart and with pulmonary stenosis; a peculiar symptom complex.","volume":"83","author":"Isler","year":"1953","journal-title":"Schweiz Med Wochenschr"},{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0002-8703(54)90152-0","article-title":"Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.","volume":"47","author":"Thorson","year":"1954","journal-title":"Am Heart J"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0002-8703(97)70053-X","article-title":"Cardiovascular complications of malignant carcinoid disease.","volume":"134","author":"Anderson","year":"1997","journal-title":"Am Heart J"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.amjcard.2007.08.045","article-title":"Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.","volume":"101","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9343(64)90145-7","article-title":"The cardiac disease associated with the carcinoid syndrome (carcinoid heart disease).","volume":"36","author":"Roberts","year":"1964","journal-title":"Am J Med"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0046-8177(76)80054-8","article-title":"The carcinoid endocardial plaque: an ultrastructural study.","volume":"7","author":"Ferrans","year":"1976","journal-title":"Hum Pathol"},{"key":"R9-2-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pcad.2006.12.002","article-title":"Carcinoid heart disease.","volume":"49","author":"Bernheim","year":"2007","journal-title":"Prog Cardiovasc Dis"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ijcard.2008.02.019","article-title":"Carcinoid heart disease.","volume":"129","author":"Gustafsson","year":"2008","journal-title":"Int J Cardiol"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/oxfordjournals.eurheartj.a061945","article-title":"Carcinoid heart disease: report of a case secondary to a pure carcinoid tumour of the ovary.","volume":"6","author":"Artaza","year":"1985","journal-title":"Eur Heart J"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0002-9343(68)90179-4","article-title":"Carcinoid heart disease from primary ovarian carcinoid tumors. A case report and review of the literature.","volume":"45","author":"Chatterjee","year":"1968","journal-title":"Am J Med"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.amjcard.2006.07.092","article-title":"Carcinoid heart disease in patients without hepatic metastases.","volume":"99","author":"Bernheim","year":"2007","journal-title":"Am J Cardiol"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.amjcard.2004.01.075","article-title":"Carcinoid heart disease associated with primary ovarian carcinoid tumor.","volume":"93","author":"Chaowalit","year":"2004","journal-title":"Am J Cardiol"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/01.CIR.87.4.1188","article-title":"Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.","volume":"87","author":"Pellikka","year":"1993","journal-title":"Circulation"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1161\/01.CIR.0000159356.42064.48","article-title":"Long-term serotonin administration induces heart valve disease in rats.","volume":"111","author":"Gustafsson","year":"2005","journal-title":"Circulation"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/CIRCULATIONAHA.105.554667","article-title":"Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in mice.","volume":"113","author":"Mekontso-Dessap","year":"2006","journal-title":"Circulation"},{"key":"R18-2-20210203","first-page":"827","article-title":"Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.","volume":"10","author":"Rajamannan","year":"2001","journal-title":"J Heart Valve Dis"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","article-title":"5-hydroxytryptamine receptors in the human cardiovascular system.","volume":"111","author":"Kaumann","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R21-2-20210203","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021451","article-title":"Factors associated with progression of carcinoid heart disease.","volume":"348","author":"Moller","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.echo.2009.05.002","article-title":"Role of serotoninergic pathways in drug-induced valvular heart disease and diagnostic features by echocardiography.","volume":"22","author":"Smith","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4065\/77.12.1280","article-title":"Valvular heart disease in patients taking pergolide.","volume":"77","author":"Pritchett","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/mds.20201","article-title":"Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists.","volume":"19","author":"Horvath","year":"2004","journal-title":"Mov Disord"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0026-895X(24)26444-0","article-title":"Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.","volume":"57","author":"Fitzgerald","year":"2000","journal-title":"Mol Pharmacol"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365528708991864","article-title":"Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush.","volume":"22","author":"Conlon","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"R28-2-20210203","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000318014","article-title":"Activin A in carcinoid heart disease: a possible role in diagnosis and pathogenesis.","volume":"92","author":"Bergestuen","year":"2010","journal-title":"Neuroendocrinology"},{"key":"R29-2-20210203","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2407-10-6","article-title":"Plasma CCN2connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors.","volume":"10","author":"Bergestuen","year":"2010","journal-title":"BMC Cancer"},{"key":"R30-2-20210203","first-page":"71","article-title":"Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease.","volume":"142","author":"Waltenberger","year":"1993","journal-title":"Am J Pathol"},{"key":"R31-2-20210203","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0002-9440(10)64489-6","article-title":"Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.","volume":"161","author":"Jian","year":"2002","journal-title":"Am J Pathol"},{"key":"R32-2-20210203","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1161\/CIRCULATIONAHA.105.553750","article-title":"Prognosis of carcinoid heart disease: analysis of 200 cases over two decades.","volume":"112","author":"Moller","year":"2005","journal-title":"Circulation"},{"key":"R33-2-20210203","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1161\/CIRCULATIONAHA.107.701367","article-title":"Carcinoid heart disease.","volume":"116","author":"Bhattacharyya","year":"2007","journal-title":"Circulation"},{"key":"R34-2-20210203","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.82.5.641","article-title":"Carcinoid constrictive pericarditis.","volume":"82","author":"Johnston","year":"1999","journal-title":"Heart"},{"key":"R36-2-20210203","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/0002-9343(84)90549-7","article-title":"Coronary artery spasm and cardiac arrest in carcinoid heart disease.","volume":"77","author":"Topol","year":"1984","journal-title":"Am J Med"},{"key":"R37-2-20210203","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp.2004.016055","article-title":"Cardiac metastasis from a bronchial carcinoid: report of a case presenting with diffuse thickening of the left ventricular wall.","volume":"57","author":"Goddard","year":"2004","journal-title":"J Clin Pathol"},{"key":"R38-2-20210203","first-page":"125","article-title":"Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.","volume":"24","author":"Boglioli","year":"1997","journal-title":"Tex Heart Inst J"},{"key":"R39-2-20210203","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/bmj.292.6526.1016","article-title":"Cyanosis attributable to right to left shunt in the carcinoid syndrome.","volume":"292","author":"Pitcher","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R40-2-20210203","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archderm.1972.01620070046016","article-title":"Pellagra and the carcinoid syndrome.","volume":"105","author":"Castiello","year":"1972","journal-title":"Arch Dermatol"},{"key":"R41-2-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF03346355","article-title":"Atypical thymic carcinoid in multiple endocrine neoplasia type 1 syndrome.","volume":"30","author":"Vidal","year":"2007","journal-title":"J Endocrinol Invest"},{"key":"R42-2-20210203","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(98)02286-7","article-title":"Carcinoid tumour.","volume":"352","author":"Caplin","year":"1998","journal-title":"Lancet"},{"key":"R43-2-20210203","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/01.CIR.92.4.790","article-title":"Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.","volume":"92","author":"Robiolio","year":"1995","journal-title":"Circulation"},{"key":"R44-2-20210203","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/0735-1097(94)00374-Y","article-title":"Outcome of cardiac surgery for carcinoid heart disease.","volume":"25","author":"Connolly","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R45-2-20210203","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.0007-1323.2001.01798.x","article-title":"Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome.","volume":"88","author":"Westberg","year":"2001","journal-title":"Br J Surg"},{"key":"R47-2-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(85)90313-4","article-title":"The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease.","volume":"79","author":"Ross","year":"1985","journal-title":"Am J Med"},{"key":"R48-2-20210203","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/clinchem\/32.5.840","article-title":"Urinary serotonin in the diagnosis of carcinoid tumors.","volume":"32","author":"Feldman","year":"1986","journal-title":"Clin Chem"},{"key":"R49-2-20210203","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/ajcn\/42.4.639","article-title":"Serotonin content of foods: effect on urinary excretion of 5-hydroxyindoleacetic acid.","volume":"42","author":"Feldman","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"R50-2-20210203","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0016-5085(86)90630-X","article-title":"Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors.","volume":"91","author":"Richter","year":"1986","journal-title":"Gastroenterology"},{"key":"R51-2-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00042737-200101000-00010","article-title":"Diagnostic value of plasma chromogranin A in neuroendocrine tumours.","volume":"13","author":"Tomassetti","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R52-2-20210203","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.2008.18.7047","article-title":"Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.","volume":"27","author":"Korse","year":"2009","journal-title":"J Clin Oncol"},{"key":"R53-2-20210203","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000179900","article-title":"Elevated plasma chromogranin A is the first indication of recurrence in radically operated midgut carcinoid tumors.","volume":"89","author":"Welin","year":"2009","journal-title":"Neuroendocrinology"},{"key":"R54-2-20210203","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/hrt.2004.040329","article-title":"Carcinoid heart disease: presentation, diagnosis, and management.","volume":"90","author":"Fox","year":"2004","journal-title":"Heart"},{"key":"R55-2-20210203","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1038\/sj.bjc.6601816","article-title":"Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease.","volume":"90","author":"Zuetenhorst","year":"2004","journal-title":"Br J Cancer"},{"key":"R56-2-20210203","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0002-9149(89)90150-1","article-title":"Plasma atrial natriuretic peptide in carcinoid heart disease.","volume":"63","author":"Lundin","year":"1989","journal-title":"Am J Cardiol"},{"key":"R57-2-20210203","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.amjcard.2008.05.047","article-title":"Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease.","volume":"102","author":"Bhattacharyya","year":"2008","journal-title":"Am J Cardiol"},{"key":"R59-2-20210203","first-page":"722","article-title":"A never-closing valve. Cardiac involvement in carcinoid syndrome.","volume":"28","author":"Casazza","year":"1998","journal-title":"G Ital Cardiol"},{"key":"R60-2-20210203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCIMAGING.109.886846","article-title":"Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI.","volume":"3","author":"Bhattacharyya","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"key":"R61-2-20210203","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0894-7317(03)00335-3","article-title":"American Society of Echocardiography. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography.","volume":"16","author":"Zoghbi","year":"2003","journal-title":"J Am Soc Echocardiogr"},{"key":"R62-2-20210203","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European Association of Echocardiography. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease).","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"R64-2-20210203","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.amjcard.2009.10.023","article-title":"Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease.","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"R65-2-20210203","first-page":"E4","article-title":"Utility of 3D transoesophageal echocardiography for the assessment of tricuspid and pulmonary valves in carcinoid heart disease.","volume":"12","author":"Bhattacharyya","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"R66-2-20210203","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.amjcard.2010.01.017","article-title":"Echocardiographic follow-up of treated patients with carcinoid syndrome.","volume":"105","author":"Mansencal","year":"2010","journal-title":"Am J Cardiol"},{"key":"R67-2-20210203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(98)00354-4","article-title":"Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease.","volume":"32","author":"Denney","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R68-2-20210203","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine.","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"R69-2-20210203","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.rct.0000181724.69597.69","article-title":"Magnetic resonance imaging diagnosis of carcinoid heart disease.","volume":"29","author":"Bastarrika","year":"2005","journal-title":"J Comput Assist Tomogr"},{"key":"R70-2-20210203","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1002\/clc.20260","article-title":"Magnetic resonance imaging of carcinoid heart disease.","volume":"32","author":"Franzen","year":"2009","journal-title":"Clin Cardiol"},{"key":"R71-2-20210203","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.crad.2008.10.013","article-title":"Cardiovascular magnetic resonance imaging in the assessment of carcinoid heart disease.","volume":"64","author":"Sandmann","year":"2009","journal-title":"Clin Radiol"},{"key":"R73-2-20210203","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1067\/j.cpradiol.2008.05.003","article-title":"Non-electrocardiogram-gated multidetector-row computed tomography findings of cardiac pathology in oncologic patients.","volume":"38","author":"Diaz","year":"2009","journal-title":"Curr Probl Diagn Radiol"},{"key":"R74-2-20210203","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11845-008-0273-5","article-title":"Cardiac carcinoid: tricuspid delayed hyperenhancement on cardiac 64-slice multidetector CT and magnetic resonance imaging.","volume":"179","author":"Martos","year":"2010","journal-title":"Ir J Med Sci"},{"key":"R75-2-20210203","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","article-title":"Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours.","volume":"35","author":"Ambrosini","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R76-2-20210203","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"R77-2-20210203","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1200\/JCO.1999.17.2.600","article-title":"Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.","volume":"17","author":"Rubin","year":"1999","journal-title":"J Clin Oncol"},{"key":"R78-2-20210203","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI117090","article-title":"Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.","volume":"93","author":"Kubota","year":"1994","journal-title":"J Clin Invest"},{"key":"R79-2-20210203","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<402::AID-CNCR25>3.0.CO;2-4","article-title":"Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group.","volume":"77","author":"di Bartolomeo","year":"1996","journal-title":"Cancer"},{"key":"R80-2-20210203","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3109\/00365528609011123","article-title":"Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial.","volume":"21","author":"Gustafsen","year":"1986","journal-title":"Scand J Gastroenterol"},{"key":"R81-2-20210203","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/1097-0142(19910101)67:1<33::AID-CNCR2820670107>3.0.CO;2-E","article-title":"A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.","volume":"67","author":"Moertel","year":"1991","journal-title":"Cancer"},{"key":"R82-2-20210203","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/0140-6736(92)91235-Z","article-title":"Ondansetron in carcinoid syndrome.","volume":"339","author":"Platt","year":"1992","journal-title":"Lancet"},{"key":"R83-2-20210203","first-page":"1297","article-title":"Treatment of malignant carcinoid tumors with human leukocyte interferon: long-term results.","volume":"70","author":"Oberg","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"R84-2-20210203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/02841868709113712","article-title":"Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin-alone or in combination with 5-FU.","volume":"26","author":"Oberg","year":"1987","journal-title":"Acta Oncol"},{"key":"R85-2-20210203","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(20010415)91:8<1543::AID-CNCR1163>3.0.CO;2-N","article-title":"A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors.","volume":"91","author":"Ansell","year":"2001","journal-title":"Cancer"},{"key":"R86-2-20210203","first-page":"627","article-title":"Treatment of metastasized midgut carcinoids with dacarbazine.","volume":"90","author":"Ritzel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"R87-2-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/02841869309083912","article-title":"Metastatic carcinoid tumors and the malignant carcinoid syndrome.","volume":"32","author":"Kvols","year":"1993","journal-title":"Acta Oncol"},{"key":"R88-2-20210203","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cgh.2005.12.008","article-title":"Therapeutic options for gastrointestinal carcinoids.","volume":"4","author":"Modlin","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R89-2-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.critrevonc.2009.01.008","article-title":"Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives.","volume":"72","author":"Capurso","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"R90-2-20210203","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(11)61742-X","article-title":"For the RADIANT-2 Study Group: Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised; placebo-controlled, phase 3 study.","volume":"378","author":"Pavel","year":"2011","journal-title":"Lancet"},{"key":"R92-2-20210203","first-page":"481","article-title":"Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.","volume":"47","author":"Grazi","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"R93-2-20210203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1072-7515(03)00230-8","article-title":"Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival.","volume":"197","author":"Sarmiento","year":"2003","journal-title":"J Am Coll Surg"},{"key":"R94-2-20210203","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0025-6196(11)60834-3","article-title":"Role of hepatic resection for patients with carcinoid heart disease.","volume":"83","author":"Bernheim","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R95-2-20210203","first-page":"325","article-title":"Hepatic artery ligation in treatment of carcinoid syndrome.","volume":"112","author":"Jugdutt","year":"1975","journal-title":"Can Med Assoc J"},{"key":"R96-2-20210203","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1002\/1097-0142(19930415)71:8<2624::AID-CNCR2820710830>3.0.CO;2-B","article-title":"Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.","volume":"71","author":"Ruszniewski","year":"1993","journal-title":"Cancer"},{"key":"R97-2-20210203","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1051-0443(99)70055-2","article-title":"Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.","volume":"10","author":"Brown","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"R98-2-20210203","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1245\/ASO.2006.03.071","article-title":"Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.","volume":"13","author":"Osborne","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R99-2-20210203","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jacc.2008.05.008","article-title":"ACCAHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of CardiologyAmerican Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"52","author":"Nishimura","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R100-2-20210203","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/0002-9149(63)90292-3","article-title":"Carcinoid heart disease. report of a case treated by open heart surgery.","volume":"12","author":"Wright","year":"1963","journal-title":"Am J Cardiol"},{"key":"R101-2-20210203","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0003-4975(98)01313-7","article-title":"Carcinoid heart disease and carcinoid syndrome: successful surgical treatment.","volume":"67","author":"McDonald","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"R105-2-20210203","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/0003-4975(94)90479-0","article-title":"Carcinoid heart disease: early failure of an allograft valve replacement.","volume":"58","author":"Ohri","year":"1994","journal-title":"Ann Thorac Surg"},{"key":"R106-2-20210203","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-5223(19)37666-4","article-title":"Porcine heterograft valve replacement in carcinoid heart disease.","volume":"81","author":"Schoen","year":"1981","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R107-2-20210203","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/0002-9149(83)90357-0","article-title":"Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis.","volume":"51","author":"Thorburn","year":"1983","journal-title":"Am J Cardiol"},{"key":"R108-2-20210203","first-page":"230","article-title":"Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology; ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.","volume":"28","author":"Vahanian","year":"2007","journal-title":"Eur Heart J"},{"key":"R110-2-20210203","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.amjcard.2007.11.056","article-title":"Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.","volume":"101","author":"Mansencal","year":"2008","journal-title":"Am J Cardiol"},{"key":"R111-2-20210203","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijcard.2008.11.180","article-title":"Patent foramen ovale in carcinoid heart disease.","volume":"142","author":"Mansencal","year":"2010","journal-title":"Int J Cardiol"},{"key":"R112-2-20210203","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/1522-726X(200010)51:2<210::AID-CCD17>3.0.CO;2-4","article-title":"Nonsurgical closure of a patent foramen ovale in a patient with carcinoid heart disease and severe hypoxia from interatrial shunting.","volume":"51","author":"Marenco","year":"2000","journal-title":"Catheter Cardiovasc Interv"},{"key":"R113-2-20210203","first-page":"47","article-title":"Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease.","volume":"9","author":"Mottram","year":"2008","journal-title":"Eur J Echocardiogr"},{"key":"R114-2-20210203","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0167-5273(94)90274-7","article-title":"Successful balloon dilatation of the pulmonary valve in carcinoid heart disease.","volume":"45","author":"Hargreaves","year":"1994","journal-title":"Int J Cardiol"},{"key":"R115-2-20210203","first-page":"115","article-title":"Balloon dilation of tricuspid and pulmonary valves in carcinoid heart disease.","volume":"20","author":"Onate","year":"1993","journal-title":"Tex Heart Inst J"},{"key":"R116-2-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/hrt.67.6.450","article-title":"Failure of balloon dilatation of the pulmonary valve in carcinoid pulmonary stenosis.","volume":"67","author":"Grant","year":"1992","journal-title":"Br Heart J"},{"key":"R117-2-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/bja\/aen237","article-title":"Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.","volume":"101","author":"Castillo","year":"2008","journal-title":"Br J Anaesth"},{"key":"R118-2-20210203","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.euje.2006.04.008","article-title":"Carcinoid crisis and reversible right ventricular dysfunction after embolization in untreated carcinoid syndrome.","volume":"8","author":"Majeed","year":"2007","journal-title":"Eur J Echocardiogr"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0b013e31824c866e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T21:54:46Z","timestamp":1742421286000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201207000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":106,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0b013e31824c866e","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}